Pirtobrutinib Targets BTK C481S in Ibrutinib-Resistant CLL but Second-Site BTK Mutations Lead to ResistanceAishath NaeemFilippo Utroet al.2023Blood Adv.
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumorsRisa BurrIgnaty Leshchineret al.2024Nat. Cancer